Skip to main content

Table 4 Clinical data of the studied patients (No. = 73)

From: Medication adherence to disease-modifying anti-rheumatic drugs among patients with rheumatoid arthritis at Assiut University Hospital, Egypt

Clinical Item

No.

Percent

DAS-28 level

 Remission < 2.6

6

8.2

 Low (2.6–< 3.2)

15

20.6

 Moderate (3.2–5.1)

33

45.2

 High > 5.1

19

26.0

 Mean ± SD

4.29 ± 1.40

 Median (range)

4.1 (2.0–7.5)

HAQ-DI level

 Mild (0–< 1)

35

47.9

 Moderate (1–< 2)

18

24.7

 Severe (2–3)

20

27.4

 Mean ± SD

1.28 ± 0.98

 Median (range)

1.1 (0.0–3.0)

Depression (score)

 No case (0–7)

36

49.3

 Borderline (8–10)

14

19.2

 Case (11–21)

23

31.5

 Mean ± SD

8.14 ± 5.74

 Median (range)

8.0 (0.0–20.0)

Anxiety (score)

 No case (0–7)

45

61.7

 Borderline (8–10)

12

16.4

 Case (11–21)

16

21.9

 Mean ± SD

6.25 ± 5.75

 Median (range)

5.0 (0.0–21.0)

  1. DAS Disease Activity Index, HAQ-DI Health Assessment Questionnaire Disability Index, No. number, SD standard deviation